Drug recall D-1473-2022

Class II Terminated reported Sep 7, 2022

Product

Neomycin Sulfate Tablets, USP 500 mg , 100-count bottles, Rx only, Distributed by: TEVA PHARMACEUTICALS USA, INC North Wales, PA 19454, NDC 0093-1177-01

Reason for recall

CGMP Deviations: A foreign matter identified as teflon was found in the Active Pharmaceutical Ingredient (API) used in the manufacture of Neomycin Sulfate Tablets, USP 500 mg.

Lots and codes

Lot #: 3007830, 3007746, 3007829, Exp. Date 10/2024

Recall details

Recalling firm
Teva Pharmaceuticals USA Inc, Parsippany, NJ
Distribution
Nationwide within the United States
Type
Voluntary: Firm initiated
Recall initiated
August 23, 2022
Terminated
September 7, 2023

Related products